Piper Sandler Maintains Overweight on Solventum, Raises Price Target to $105
سولفنتوم
Solventum Corporation SOLV | 0.00 |
Piper Sandler analyst Jason Bednar maintains Solventum (NYSE:
SOLV) with a Overweight and raises the price target from $92 to $105.
